Pierre Van Mol

1.5k total citations
10 papers, 239 citations indexed

About

Pierre Van Mol is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Pierre Van Mol has authored 10 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Epidemiology. Recurrent topics in Pierre Van Mol's work include Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers) and Ultrasound in Clinical Applications (2 papers). Pierre Van Mol is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers) and Ultrasound in Clinical Applications (2 papers). Pierre Van Mol collaborates with scholars based in Belgium, Greece and United Kingdom. Pierre Van Mol's co-authors include Els Wauters, Johan Vansteenkiste, C. Van De Kerkhove, Lizza Hendriks, Bart Reymen, Dirk De Ruysscher, Francesco Cortiula, Solange Peters, Stéphanie Humblet‐Baron and Joost Wauters and has published in prestigious journals such as Annals of Oncology, Cellular and Molecular Life Sciences and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Pierre Van Mol

9 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Van Mol Belgium 5 107 98 65 52 41 10 239
Lishu Zhao China 10 109 1.0× 87 0.9× 74 1.1× 19 0.4× 40 1.0× 30 235
Maria Chiara Parati Italy 9 204 1.9× 114 1.2× 54 0.8× 40 0.8× 20 0.5× 21 295
Yuequan Shi China 10 170 1.6× 89 0.9× 43 0.7× 17 0.3× 60 1.5× 27 265
Xidong Ma China 10 88 0.8× 78 0.8× 50 0.8× 32 0.6× 35 0.9× 26 227
Gianluca Businello Italy 10 116 1.1× 86 0.9× 60 0.9× 18 0.3× 24 0.6× 22 264
Marco Polo Peralta Álvarez Mexico 6 123 1.1× 87 0.9× 38 0.6× 29 0.6× 44 1.1× 12 199
Sandra Assoun France 7 185 1.7× 137 1.4× 54 0.8× 35 0.7× 34 0.8× 8 262
Rabin Niroula United States 6 58 0.5× 29 0.3× 119 1.8× 26 0.5× 35 0.9× 23 284
Georgia-Angeliki Koliou Greece 8 101 0.9× 29 0.3× 54 0.8× 29 0.6× 16 0.4× 34 195
Gareth Rivalland Australia 10 112 1.0× 98 1.0× 78 1.2× 7 0.1× 69 1.7× 26 248

Countries citing papers authored by Pierre Van Mol

Since Specialization
Citations

This map shows the geographic impact of Pierre Van Mol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Van Mol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Van Mol more than expected).

Fields of papers citing papers by Pierre Van Mol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Van Mol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Van Mol. The network helps show where Pierre Van Mol may publish in the future.

Co-authorship network of co-authors of Pierre Van Mol

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Van Mol. A scholar is included among the top collaborators of Pierre Van Mol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Van Mol. Pierre Van Mol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Cambier, Seppe, Noëmie Pörtner, Mieke Metzemaekers, et al.. (2023). Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients. Cellular and Molecular Life Sciences. 80(8). 234–234. 6 indexed citations
2.
Mol, Pierre Van, et al.. (2023). Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients. International review of cell and molecular biology. 382. 181–206. 1 indexed citations
3.
Cortiula, Francesco, Bart Reymen, Solange Peters, et al.. (2022). Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches. Annals of Oncology. 33(9). 893–908. 61 indexed citations
4.
Franken, Amelie, Pierre Van Mol, Rogier Schepers, et al.. (2022). Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis. Journal for ImmunoTherapy of Cancer. 10(9). e005323–e005323. 39 indexed citations
5.
Kalkanis, Alexandros, Zafeiris Louvaris, Laurent Godinas, et al.. (2022). Lung Aeration in COVID-19 Pneumonia by Ultrasonography and Computed Tomography. Journal of Clinical Medicine. 11(10). 2718–2718. 2 indexed citations
6.
Kalkanis, Alexandros, Els Wauters, Dries Testelmans, et al.. (2021). Early lung ultrasound assessment for the prognosis of patients hospitalized for COVID-19 pneumonia. A pilot study. Respiratory Medicine and Research. 80. 100832–100832. 2 indexed citations
7.
Mol, Pierre Van, Amelie Franken, Christophe Dooms, et al.. (2020). LBA78 A microsimulation model to assess the impact of SARS-CoV-2 on cancer outcomes, healthcare organization and economic burden. Annals of Oncology. 31. S1207–S1207. 3 indexed citations
8.
Neumann, Julika, Teresa Prezzemolo, Lore Vanderbeke, et al.. (2020). Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19. Clinical & Translational Immunology. 9(11). e1204–e1204. 58 indexed citations
9.
Vansteenkiste, Johan, C. Van De Kerkhove, Els Wauters, & Pierre Van Mol. (2019). Capmatinib for the treatment of non-small cell lung cancer. Expert Review of Anticancer Therapy. 19(8). 659–671. 67 indexed citations
10.
Mol, Pierre Van, et al.. (2018). Dysphagia during glucocorticoid treatment of dermatomyositis: a differential diagnostic challenge. Rheumatology Advances in Practice. 2(1). rky010–rky010.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lishu Zhao Breakdown of academic impact, for papers by Maria Chiara Parati Breakdown of academic impact, for papers by Yuequan Shi Breakdown of academic impact, for papers by Xidong Ma Breakdown of academic impact, for papers by Gianluca Businello Breakdown of academic impact, for papers by Marco Polo Peralta Álvarez Breakdown of academic impact, for papers by Sandra Assoun Breakdown of academic impact, for papers by Rabin Niroula Breakdown of academic impact, for papers by Georgia-Angeliki Koliou Breakdown of academic impact, for papers by Gareth Rivalland
Rankless by CCL
2026